HIF1A and stroke disorder: Administration of HIF-1α-siRNA significantly reduces the content of p53 and caspase-3 and is accompanied by decreased VEGF expression, thus alleviating stroke-related behavior disorders and cerebral infarction at 1 h after MCAO (34).